XML 53 R42.htm IDEA: XBRL DOCUMENT v3.20.2
License, Acquisition and Collaboration Agreements - Primatope Stock Purchase Option Agreement (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2019
USD ($)
Sep. 30, 2017
USD ($)
item
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
License and Acquisition Agreements              
Research and development     $ 22,324 $ 30,848 $ 43,225 $ 90,101  
Primatope | Stock Option Purchase Agreement              
License and Acquisition Agreements              
Percentage of capital stock available to purchase in call option   100.00%          
Payment for extension of option period             $ 800
Primatope Acquisition              
License and Acquisition Agreements              
Purchase price $ 15,000            
Upfront consideration payable on exercise of call option to acquire all outstanding equity 10,000            
Milestone payment payable after achievement of specified milestones $ 5,000     $ 3,000   3,000  
Research and development           $ 18,000  
Primatope Acquisition | Stock Option Purchase Agreement              
License and Acquisition Agreements              
Upfront payment for initial option period   $ 500          
Maximum | Primatope | Stock Option Purchase Agreement              
License and Acquisition Agreements              
Number of extensions allowed for initial option period | item   3          
Total aggregate extension payments   $ 800